|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
Эͬ���� |
|
�����ҩ�� |
| ��������������� | |
|
���������� |
|
��ά����У |
| PubMed | |
|
Article by |
|
Article by |
�����ҩ���Эͬ����
����������, ��ά����У
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���
Ŀǰ�����Ⱦ,�����ǽ�ĸ����Ⱦ�ķ����ʺ����ض��ڲ�������,����������ҩ����ij��ֿ�ѡ���ҩ���ֺ�����,��Щ�����Ӷ���ҩ��������;���������������dz���ͨ������Ӧ�ÿ����ҩ��,����Эͬ���ôӶ��ؿ�����,���ɱ�����Բ��ҽ�����ҩ���ա����������������о��ij��÷�������Ը��ֲ�ͬ�������������Ӧ�õ�ҩ�
[2] Polak A.Combination of amorolfine with various antifungal drugs in dermatophytosis.Mycoses,1993,36(1-2):43-49.
[3] Baran R,Feuilhade M,Datry A,et al.A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.Br J Dermatol,2000,142(6):1177-1183.
[4] Barchiesi F,Falconi Di Francesco L,Scaliso G.In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.Antiricrob Agents Chemother,1997,41(8):1812-1814.
[5] Barchiesi F,Di Francesco LF,Compagnucei P,et al.In-vitro interaction of terbinafine with amphotericin B,fluconazole and itraconazole against clinical isolates of Candida albicans.J Antimicrob Chemother,1998,41(1):59-65.
[6] Ryder NS.Activity of terbinafine against serious fungal pathogens.Mycoses,1999,42(Suppl 2):115-119.
[7] Shenep JL,English K,Kaufnmn L,et al.Successful medical therapy for deeply invasive facial infection due to Pythiuminsidiosum.Clin Infect Dis,1999,27:1812-1814.
[8] Sanyal AK,Roy D,Chowdhury B,et al.Ibuprofen,an unique anti-inflammatory compound activity against dermatophytes.Lett Appl Microbiol,1993,17:109-111.
[9] Scott EM,Tariq VN,McCrory RM,et al.Demonstration of synergy with fluconazole and either ibuprofen,sodium salicylate,or propylparaben against Candida albicans in vitro.Antimicrob Agents Chemother,1995,39(12):2610-2614.
[10] Tariq VN,Scott EM,McCain NE,et al.Use of decinal assay for additivity to demonstrate synergy in pair combinations of econazole,nikkomycin Z,and ibuprofen against Candida albicans in vitro.Antimicrob Agents Chemother,1995,39(12):2615-2619.
[11] Hector RF,Schaller K.Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo.Antinicrob Agents Chemother,1992,36(6):1284-1289.
[12] Li RK,Rinaldi MG.In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole.Antimicrob Agents Chemother,1999,43(6):1401-1405.
[13] Yanmne N,Behiry IK,Tosaka M,et al.Determination of in vitro synergy when amphotericin B is combined with various antimicrobial agents against yeasts by using a colorimetric microdilution checkerboard.Rinsho Byori,1997,45(7):689-695.
[14] Chin NX,Weitzman I,Della-Latta P.In vitro activity of fluvastatin,a cholesterol-lowering agent,and synergy with flucanazole and itraconazole against Caadida species and Cryptococus neoformans.Antimicrob Agents Chemother,1997,41(4):850-852.
[15] McElhaney-Feser GE,Raulli RE,Cihlar RL.Synergy of nitric oxide and azoles against Canadida species in vitro.Antimicrob Agents Chemother,1998,42(9):2342-2346.
[16] Kuipers ME,de Vries HG,Eikelboom MC,et al.Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.Antimicrob Agents Chemother,1999,43 (11):2635-2641.
[17] Nguyen MH,Barchiesi F,McGough DA,et al.In vitro evaluation of combination of fluconazole and flucytosine against Cryptocoaus neoformans var.neoformmanas.Antimicrob Agents Chemother,1995,39 (8):1691-1695.
[18] Barchiesi F,Gallo D,Caselli F,et al.In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.J Antimicrob Chemother,1999,44(1):65-70.
[19] Barchiesi F,Schimizzi AM,Caselli F,et al.Interactions between triazoles and amphotericin B against Cryptococcus neoformans.Antimicrob Agents Chemother,2000,44(9):2435-2441.
[20] Ribner B,Keusch GT,Hanna BA,et al.Combination amphotericin B-rifampin therapy for ptulmonary aspergillosis in a leukemic patient.Chest,1976,70(5):681-683.
[21] Clancy CJ,Yu YC,Lewin A,et al.Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusariurm:demonstration of in vitro synergy between rifalutin and amphotericin B.Antimicrob Agents Chemother,1998,42(3):509-513.
[22] Nguyen MH,Clancy CJ,Yu YC,et al.Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species.Eur J Clin Microbiol Infect Dis,1997,16(11):846-848.
[23] Barrios NJ,Kirkpatrick DV,Murciano A,et al.Successful treatment of disseminated Fusarium infection in an immunocompmmised child.Am J Pediatr Hematol Oncol,1990,12(3):319-324.
[24] Clancy CJ,Nguyen MH.The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fuariosis.J Antimicrob Chemother,1998,41(1):127-130.
[25] Clancy CJ,Wingard JR,Hong Nguyen M.Subcutaneous phaeohyomycosis in transplant recipients:review of the luterature and demonstration of in vitro synergy between antifungal agents.Med Mycol,2000,38(2):169-175.